Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma
Clinical trial NCT01335399 · COMPLETED
Trial details
- NCT number
- NCT01335399
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-04
- Primary completion
- 2019-10-01
- Enrollment
- 748
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.